$Management of hyperlipidemia in children with refractory nephrotic syndrome: The effect of statin therapy$

Management of hyperlipidemia in children with refractory nephrotic syndrome: The effect of statin therapy

The efficacy and safety of hydroxymethylglutaric coenzyme A reductase inhibitor (statins) in the treatment of hyperlipidemia were evaluated in 12 infants and children with steroid-resistant nephrotic syndrome followed prospectively for 1 to 5 years. All patients experienced a hypolipidemic response...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of pediatrics 1997-03, Vol.130 (3), p.470-474
Hauptverfasser:	Sanjad, Sami A., Al-Abbad, Abbas, Al-Shorafa, Saleh
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Child Child, Preschool Female General and cellular metabolism. Vitamins Humans Hydroxymethylglutaryl CoA Reductases Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hyperlipidemias - drug therapy Hyperlipidemias - etiology Hypolipidemic Agents - therapeutic use Infant Lipids - blood Male Medical sciences Nephrotic Syndrome - complications Nephrotic Syndrome - drug therapy Pharmacology. Drug treatments Proteins - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!